Sung Yoon Baek

Title: Innovations and Contributions of Inventor Sung Yoon Baek

Introduction

Sung Yoon Baek is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit β-lactamase. With a total of 9 patents to his name, Baek's work has the potential to impact medical treatments significantly.

Latest Patents

Baek's latest patents include compositions and methods for inhibiting β-lactamase. He has developed substituted dihydroisoxazole derivatives that serve as effective inhibitors of β-lactamases, which are crucial in combating antibiotic resistance. Another notable patent involves a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate. This invention demonstrates excellent stability in high-temperature and humidity environments, making it suitable for preventing or treating various diseases, including thrombosis and myocardial infarction.

Career Highlights

Throughout his career, Baek has worked with notable companies such as Legochem Biosciences, Inc. and Legochem Bioscience Ltd. His expertise in pharmaceutical sciences has allowed him to contribute to innovative solutions in the medical field.

Collaborations

Baek has collaborated with esteemed colleagues, including Young Lag Cho and Yong Zu Kim. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking inventions.

Conclusion

Sung Yoon Baek's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and drug development.